The Future of Biotech in China Will China Overcome Its Barriers? Recent trends in the pharmaceutical industry show an increase in the development and manufacturing of biological products. Although bio-pharmaceutical manufacturing has been greatly facilitated by the development of new technologies, difficulties persist in regulating biological products manufactured in different facilities, particularly ones at…
Patient Recruitment in Clinical Trials Highly successful patient recruitment and lower costs in many countries have spurred the surge in globalization of clinical trials. Increasingly, international clinical trials are conducted in developing regions including several countries in Latin America, Central and Eastern Europe (CEE), and Asia. Patient recruitment rates depend on a variety of factors,…
The Missing Minorities The missing minorities or the inadequate representation of ethnic and racial minority groups in clinical trials taking place in the United States is currently of great concern. Although minority groups should not carry an unfair burden in clinical research, they also should not be excluded from participation in clinical trials.1 Research…
Global Clinical Trials: Language & Culture By Karen Politis Virk, MS Many emerging countries, such as India, China, Mexico, Brazil, and Russia, are rapidly becoming prominent outsourcing locations for clinical research. A wider availability of patients, low operational costs and positive patient attitudes towards global clinical trials has driven this trend. These developments have…
CLINICAL TRIALS IN SOUTH AFRICA …
Clinical Trials in India: What are the Challenges? By Karen Politis Virk As demands for reducing drug development costs and achieving higher patient recruitment rates increase, India is projected to become a dominant clinical trial location. By 2011, it is expected that clinical trials in India will equal 15% of the total number of global…
CLINICAL TRIALS IN CENTRAL & EASTERN EUROPE: Multiple Cultures By Karen Politis Virk As costs for drug development in the United States (U.S.) increase, pharmaceutical and biotech companies are increasingly considering clinical studies abroad. This is in large part due to the fact that many countries can conduct clinical trials at a lower cost than…
Clinical Trial Boom in China Due to unprecedented economic growth and increased healthcare expenditures, experts predict that by 2012 China will be the world’s fourth largest pharmaceutical market. In addition to increased production and distribution by foreign pharmaceuticals, China has become one of the region’s primary locations for outsourcing clinical trials. Growth in the clinical…
Latin America Medical Trials Climate By Karen Politis Virk Several countries in Central and Eastern Europe, Asia, and Latin America are among the most prominent new locations for outsourcing clinical trials. In the past, few clinical trials were conducted in Latin America due to a number of factors, including poverty, political instability, and lack…
Why Translate? There are many reasons why a company may decide to translate a document. Perhaps they’ve formed a new partnership abroad or they want to expand their customer base. New business challenges and opportunities constantly arise, and translation, or the process of rendering written texts in one language (the source language) in another (the target language), is one way to meet those demands, no matter which business sector you are in. Language is one of the most important “currencies” in the global market.